查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1728089

睪固酮替代療法市場－全球產業規模、佔有率、趨勢、機會和預測，按適應症、產品類型、藥物活性、配銷通路、地區和競爭進行細分，2020 年至 2030 年

Testosterone Replacement Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication, By Product Type, By Drug Active, By Distribution Channel, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球睪固酮替代療法市場價值為 5.8726 億美元，預計到 2030 年將達到 9.4753 億美元，預測期內複合年成長率為 8.30%。睾酮替代療法 (TRT) 是一種醫療干預措施，旨在治療被診斷患有睾酮缺乏症或性腺功能低下的患者。這種疾病在老年男性中更為常見，會導致疲勞、肌肉量下降、性慾下降和情緒波動等症狀。 TRT 通常從全面的醫學評估和荷爾蒙水平評估開始，然後制定個人化的治療計劃。人們對睪固酮缺乏症及其對男性健康影響的認知不斷提高，加上更便捷的給藥方法（包括外用凝膠、長效注射和頰片）的開發，推動了市場的成長。此外，人口老化和個人化醫療保健的興起在 TRT 需求成長中發揮了關鍵作用。

市場概覽
預測期 2026-2030
2024年市場規模 5.8726億美元
2030年市場規模 9.4753億美元
2025-2030 年複合年成長率 8.30%
成長最快的領域 網路藥局
最大的市場 北美洲

關鍵市場促進因素

藥物輸送的進展

主要市場挑戰

恥辱和誤解

主要市場趨勢

客製化治療方案

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球睾酮替代療法市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依適應症（自體免疫疾病、遺傳性疾病、性腺功能低下、性器官手術）
    • 依產品類型（頰黏合劑、凝膠或乳膏、植入物、口服劑、腸外劑、貼片）
    • 依藥物活性（甲基睾酮、環戊丙酸睾酮、庚酸睾酮）
    • 按配銷通路（醫院藥房、網路藥房、零售藥房）
    • 按國家/地區
    • 按公司分類（2024）
  • 市場地圖

第6章：亞太地區睪固酮替代療法市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第7章：歐洲睾酮替代療法市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第8章：北美睾酮替代療法市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第9章：南美洲睪酮替代療法市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲睾酮替代療法市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章：全球睪酮替代療法市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章： 大環境分析

第 16 章：競爭格局

  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Perrigo Company plc
  • Cipla Limited
  • Sun Pharmaceuticals Industries Ltd.
  • Johnsons & Johnsons Services Inc
  • Sanofi SA
  • GSK Plc.
  • Pfizer Inc.

第 17 章：策略建議

第18章調查會社について,免責事項

簡介目錄
Product Code: 16979

The Global Testosterone Replacement Therapy Market was valued at USD 587.26 Million in 2024 and is anticipated to reach USD 947.53 Million by 2030, expanding at a CAGR of 8.30% during the forecast period. Testosterone Replacement Therapy (TRT) is a medical intervention designed to treat individuals diagnosed with testosterone deficiency or hypogonadism. This condition, more prevalent in aging men, can lead to symptoms such as fatigue, reduced muscle mass, decreased libido, and mood fluctuations. TRT typically begins with thorough medical assessments and hormone level evaluations, followed by tailored treatment plans. Increased awareness of testosterone deficiency and its impact on men's health, along with the development of more convenient delivery methods-including topical gels, long-acting injectables, and buccal tablets-has fueled market growth. Additionally, the aging population and rise of personalized healthcare have played a critical role in the growing demand for TRT.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 587.26 Million
Market Size 2030USD 947.53 Million
CAGR 2025-20308.30%
Fastest Growing SegmentOnline Pharmacy
Largest MarketNorth America

Key Market Drivers

Advancements in Drug Delivery

Recent innovations in drug delivery systems have significantly improved the efficacy and convenience of Testosterone Replacement Therapy. Transdermal patches are favored for their consistent hormone release and discreet application on the skin. Topical gels, like AndroGel and Testim, are easily applied and allow flexible dosing. Buccal tablets, placed between the gum and cheek, offer a non-invasive alternative for those avoiding injections. Long-acting injectables, such as testosterone undecanoate, require less frequent administration-every 8 to 12 weeks-enhancing patient compliance. Testosterone pellets, implanted subcutaneously, provide long-term hormone delivery with minimal maintenance. Nasal gel formulations and emerging micro-needle patches offer additional non-invasive methods for testosterone administration. Furthermore, implantable devices under development aim to deliver continuous hormone release over extended periods. With telemedicine integration, patients now have easier access to consultations and prescriptions, improving adherence and broadening the market's reach.

Key Market Challenges

Stigma and Misconceptions

The market faces challenges stemming from societal stigma and misunderstandings surrounding TRT. A common misconception is that TRT is predominantly used for athletic performance enhancement, overshadowing its legitimate use in medically diagnosed hypogonadism. Negative associations with steroid abuse in sports further fuel skepticism and distrust. Additionally, overpromotion of "Low T" symptoms in media campaigns has raised concerns about overdiagnosis and inappropriate prescriptions. Fears surrounding side effects and perceived risks can discourage both patients and physicians from considering TRT. Cultural attitudes linking testosterone deficiency to diminished masculinity may prevent men from seeking help, reinforcing feelings of embarrassment. Moreover, insufficient knowledge among both healthcare providers and the public can lead to hesitancy or misinformation about the therapy's effectiveness and safety.

Key Market Trends

Customized Treatment Plans

Customized treatment plans are becoming central to Testosterone Replacement Therapy, emphasizing individualized, patient-centric approaches. These plans involve comprehensive evaluations to determine the optimal dosage and method of administration based on each patient's hormone levels, symptoms, and medical history. Ongoing monitoring ensures that treatment remains both effective and safe, allowing timely adjustments to dosage or delivery method. Healthcare providers also assess other health factors, such as cardiovascular and prostate health, to mitigate risks. Lifestyle aspects-such as diet, sleep, exercise, and stress-are increasingly integrated into treatment strategies to maximize results. Patients are actively engaged in their care decisions, selecting preferred delivery options like gels, injections, patches, or buccal tablets, which enhances satisfaction and treatment adherence. The growing emphasis on personalization reflects broader trends in modern medicine and supports better health outcomes.

Key Market Players

  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Perrigo Company plc
  • Cipla Limited
  • Sun Pharmaceuticals Industries Ltd.
  • Sanofi SA
  • Johnsons & Johnsons Services Inc
  • GSK Plc.

Report Scope:

In this report, the Global Testosterone Replacement Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Testosterone Replacement Therapy Market, By Indication:

  • Autoimmune Conditions
  • Genetic Disorders
  • Hypogonadism
  • Sex Organ Surgeries

Testosterone Replacement Therapy Market, By Product Type:

  • Buccal Adhesive
  • Gel or Creams
  • Implants
  • Oral
  • Parenteral
  • Patches

Testosterone Replacement Therapy Market, By Drug Active:

  • Methyltestosterone
  • Testosterone Cypionate
  • Testosterone Enanthate

Testosterone Replacement Therapy Market, By Distribution Channel:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Global Testosterone Replacement Therapy Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Australia
    • Japan
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Testosterone Replacement Therapy Market.

Available Customizations:

Global Testosterone Replacement Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Testosterone Replacement Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Indication (Autoimmune Conditions, Genetic Disorders, Hypogonadism, Sex Organ Surgeries)
    • 5.2.2. By Product Type (Buccal Adhesive, Gel or Creams, Implants, Oral, Parenteral, Patches)
    • 5.2.3. By Drug Active (Methyltestosterone, Testosterone Cypionate, Testosterone Enanthate)
    • 5.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
    • 5.2.5. By Country
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. Asia Pacific Testosterone Replacement Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Indication
    • 6.2.2. By Product Type
    • 6.2.3. By Drug Active
    • 6.2.4. By Distribution Channel
    • 6.2.5. By Country
  • 6.3. Asia Pacific: Country Analysis
    • 6.3.1. China Testosterone Replacement Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Indication
        • 6.3.1.2.2. By Product Type
        • 6.3.1.2.3. By Drug Active
        • 6.3.1.2.4. By Distribution Channel
    • 6.3.2. India Testosterone Replacement Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Indication
        • 6.3.2.2.2. By Product Type
        • 6.3.2.2.3. By Drug Active
        • 6.3.2.2.4. By Distribution Channel
    • 6.3.3. Australia Testosterone Replacement Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Indication
        • 6.3.3.2.2. By Product Type
        • 6.3.3.2.3. By Drug Active
        • 6.3.3.2.4. By Distribution Channel
    • 6.3.4. Japan Testosterone Replacement Therapy Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Indication
        • 6.3.4.2.2. By Product Type
        • 6.3.4.2.3. By Drug Active
        • 6.3.4.2.4. By Distribution Channel
    • 6.3.5. South Korea Testosterone Replacement Therapy Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Indication
        • 6.3.5.2.2. By Product Type
        • 6.3.5.2.3. By Drug Active
        • 6.3.5.2.4. By Distribution Channel

7. Europe Testosterone Replacement Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Indication
    • 7.2.2. By Product Type
    • 7.2.3. By Drug Active
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Testosterone Replacement Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Indication
        • 7.3.1.2.2. By Product Type
        • 7.3.1.2.3. By Drug Active
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. Germany Testosterone Replacement Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Indication
        • 7.3.2.2.2. By Product Type
        • 7.3.2.2.3. By Drug Active
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. Spain Testosterone Replacement Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Indication
        • 7.3.3.2.2. By Product Type
        • 7.3.3.2.3. By Drug Active
        • 7.3.3.2.4. By Distribution Channel
    • 7.3.4. Italy Testosterone Replacement Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Indication
        • 7.3.4.2.2. By Product Type
        • 7.3.4.2.3. By Drug Active
        • 7.3.4.2.4. By Distribution Channel
    • 7.3.5. United Kingdom Testosterone Replacement Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Indication
        • 7.3.5.2.2. By Product Type
        • 7.3.5.2.3. By Drug Active
        • 7.3.5.2.4. By Distribution Channel

8. North America Testosterone Replacement Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Indication
    • 8.2.2. By Product Type
    • 8.2.3. By Drug Active
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Testosterone Replacement Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Indication
        • 8.3.1.2.2. By Product Type
        • 8.3.1.2.3. By Drug Active
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. Mexico Testosterone Replacement Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Indication
        • 8.3.2.2.2. By Product Type
        • 8.3.2.2.3. By Drug Active
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. Canada Testosterone Replacement Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Indication
        • 8.3.3.2.2. By Product Type
        • 8.3.3.2.3. By Drug Active
        • 8.3.3.2.4. By Distribution Channel

9. South America Testosterone Replacement Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Indication
    • 9.2.2. By Product Type
    • 9.2.3. By Drug Active
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Testosterone Replacement Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Indication
        • 9.3.1.2.2. By Product Type
        • 9.3.1.2.3. By Drug Active
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. Argentina Testosterone Replacement Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Indication
        • 9.3.2.2.2. By Product Type
        • 9.3.2.2.3. By Drug Active
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Colombia Testosterone Replacement Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Indication
        • 9.3.3.2.2. By Product Type
        • 9.3.3.2.3. By Drug Active
        • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Testosterone Replacement Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Indication
    • 10.2.2. By Product Type
    • 10.2.3. By Drug Active
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Testosterone Replacement Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Indication
        • 10.3.1.2.2. By Product Type
        • 10.3.1.2.3. By Drug Active
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Saudi Arabia Testosterone Replacement Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Indication
        • 10.3.2.2.2. By Product Type
        • 10.3.2.2.3. By Drug Active
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. UAE Testosterone Replacement Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Indication
        • 10.3.3.2.2. By Product Type
        • 10.3.3.2.3. By Drug Active
        • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Testosterone Replacement Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

  • 16.1. AbbVie Inc.
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (In case of listed companies)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. Bausch Health Companies Inc.
  • 16.3. Teva Pharmaceutical Industries Ltd.
  • 16.4. Perrigo Company plc
  • 16.5. Cipla Limited
  • 16.6. Sun Pharmaceuticals Industries Ltd.
  • 16.7. Johnsons & Johnsons Services Inc
  • 16.8. Sanofi SA
  • 16.9. GSK Plc.
  • 16.10.Pfizer Inc.

17. Strategic Recommendations

18. About Us & Disclaimer